| Drug Name |
Amprenavir |
| Drug ID |
BADD_D00136 |
| Description |
Amprenavir is a protease inhibitor used to treat HIV infection. |
| Indications and Usage |
For the treatment of HIV-1 infection in combination with other antiretroviral agents. |
| Marketing Status |
approved; investigational |
| ATC Code |
J05AE05 |
| DrugBank ID |
DB00701
|
| KEGG ID |
D00894
|
| MeSH ID |
C095108
|
| PubChem ID |
65016
|
| TTD Drug ID |
D0A0OO
|
| NDC Product Code |
Not Available |
| UNII |
5S0W860XNR
|
| Synonyms |
amprenavir | tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate | (3S-(3R*(1R*,2S*)))-(3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate | VX 478 | VX-478 | Vertex VX478 | Agenerase |
